APO Research

APO RESEARCH · REPORT

Angiotensin II Receptor

Selected research

Industry Growth & Trends

Global Angiotensin II Receptor Industry Growth and Trends Forecast to 2032

Market perspective

The global Angiotensin II Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Angiotensin II Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Angiotensin II Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiotensin II Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Angiotensin II Receptor include CJ HealthCare Corp, MorphoSys AG, Vicore Pharma AB and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Angiotensin II Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Angiotensin II Receptor market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Angiotensin II Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Angiotensin II Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Angiotensin II Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Angiotensin II Receptor Market by Company

CJ HealthCare Corp

MorphoSys AG

Vicore Pharma AB

Novartis AG

Angiotensin II Receptor Segment by Type

MOR-107

KDT-501

EMA-401

C-21

Others

Angiotensin II Receptor Segment by Application

Women's Health

Immunology

Acute Ischemic Stroke

Respiratory

Others

Angiotensin II Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Angiotensin II Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Angiotensin II Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of MOR-107 Table 2. Major Company of KDT-501 Table 3. Major Company of EMA-401 Table 4. Major Company of C-21 Table 5. Major Company of Others Table 6. Global Angiotensin II Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 8. Global Angiotensin II Receptor Sales Market Share in Volume by Type (2021-2026) Table 9. Global Angiotensin II Receptor Sales by Type (2021-2026) & (US$ Million) Table 10. Global Angiotensin II Receptor Sales Market Share in Value by Type (2021-2026) Table 11. Global Angiotensin II Receptor Price by Type (2021-2026) & (US$/unit) Table 12. Global Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 13. Global Angiotensin II Receptor Sales Market Share in Volume by Type (2027-2032) Table 14. Global Angiotensin II Receptor Sales by Type (2027-2032) & (US$ Million) Table 15. Global Angiotensin II Receptor Sales Market Share in Value by Type (2027-2032) Table 16. Global Angiotensin II Receptor Price by Type (2027-2032) & (US$/unit) Table 17. North America Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 18. North America Angiotensin II Receptor Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 20. Europe Angiotensin II Receptor Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Angiotensin II Receptor Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 24. Latin America Angiotensin II Receptor Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Angiotensin II Receptor Sales by Type (2021-2026) & (US$ Million) Table 27. Angiotensin II Receptor Industry Trends Table 28. Angiotensin II Receptor Industry Drivers Table 29. Angiotensin II Receptor Industry Opportunities and Challenges Table 30. Angiotensin II Receptor Industry Restraints Table 31. Global Angiotensin II Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Angiotensin II Receptor Revenue Market Share by Company (2021-2026) Table 33. Global Angiotensin II Receptor Sales by Company (2021-2026) & (k units) Table 34. Global Angiotensin II Receptor Sales Share by Company (2021-2026) Table 35. Global Angiotensin II Receptor Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Angiotensin II Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Angiotensin II Receptor Major Company Production Sites and Headquarters Table 38. Global Angiotensin II Receptor Company, Product Type & Application Table 39. Global Angiotensin II Receptor Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Angiotensin II Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Angiotensin II Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Angiotensin II Receptor Sales by Region (2021-2026) & (k units) Table 44. Global Angiotensin II Receptor Sales Market Share in Volume by Region (2021-2026) Table 45. Global Angiotensin II Receptor Sales by Region (2021-2026) & (US$ Million) Table 46. Global Angiotensin II Receptor Sales Market Share in Value by Region (2021-2026) Table 47. Global Angiotensin II Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Angiotensin II Receptor Sales by Region (2027-2032) & (k units) Table 49. Global Angiotensin II Receptor Sales Market Share in Volume by Region (2027-2032) Table 50. Global Angiotensin II Receptor Sales by Region (2027-2032) & (US$ Million) Table 51. Global Angiotensin II Receptor Sales Market Share in Value by Region (2027-2032) Table 52. Global Angiotensin II Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Angiotensin II Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 55. Global Angiotensin II Receptor Sales Market Share in Volume by Application (2021-2026) Table 56. Global Angiotensin II Receptor Sales by Application (2021-2026) & (US$ Million) Table 57. Global Angiotensin II Receptor Sales Market Share in Value by Application (2021-2026) Table 58. Global Angiotensin II Receptor Price by Application (2021-2026) & (US$/unit) Table 59. Global Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 60. Global Angiotensin II Receptor Sales Market Share in Volume by Application (2027-2032) Table 61. Global Angiotensin II Receptor Sales by Application (2027-2032) & (US$ Million) Table 62. Global Angiotensin II Receptor Sales Market Share in Value by Application (2027-2032) Table 63. Global Angiotensin II Receptor Price by Application (2027-2032) & (US$/unit) Table 64. North America Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 65. North America Angiotensin II Receptor Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 67. Europe Angiotensin II Receptor Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Angiotensin II Receptor Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 71. Latin America Angiotensin II Receptor Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Angiotensin II Receptor Sales by Application (2021-2026) & (US$ Million) Table 74. CJ HealthCare Corp Company Information Table 75. CJ HealthCare Corp Business Overview Table 76. CJ HealthCare Corp Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. CJ HealthCare Corp Angiotensin II Receptor Product Portfolio Table 78. CJ HealthCare Corp Recent Development Table 79. MorphoSys AG Company Information Table 80. MorphoSys AG Business Overview Table 81. MorphoSys AG Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. MorphoSys AG Angiotensin II Receptor Product Portfolio Table 83. MorphoSys AG Recent Development Table 84. Vicore Pharma AB Company Information Table 85. Vicore Pharma AB Business Overview Table 86. Vicore Pharma AB Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Vicore Pharma AB Angiotensin II Receptor Product Portfolio Table 88. Vicore Pharma AB Recent Development Table 89. Novartis AG Company Information Table 90. Novartis AG Business Overview Table 91. Novartis AG Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Novartis AG Angiotensin II Receptor Product Portfolio Table 93. Novartis AG Recent Development Table 94. North America Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 95. North America Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 96. North America Angiotensin II Receptor Sales Market Share by Country (2021-2026) Table 97. North America Angiotensin II Receptor Sales Forecast by Country (2027-2032) & (k units) Table 98. North America Angiotensin II Receptor Sales Market Share Forecast by Country (2027-2032) Table 99. North America Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Angiotensin II Receptor Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Angiotensin II Receptor Market Share by Country (2021-2026) Table 102. North America Angiotensin II Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Angiotensin II Receptor Market Share Forecast by Country (2027-2032) Table 104. Europe Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 105. Europe Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 106. Europe Angiotensin II Receptor Sales Market Share by Country (2021-2026) Table 107. Europe Angiotensin II Receptor Sales Forecast by Country (2027-2032) & (k units) Table 108. Europe Angiotensin II Receptor Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Angiotensin II Receptor Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Angiotensin II Receptor Market Share by Country (2021-2026) Table 112. Europe Angiotensin II Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Angiotensin II Receptor Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 116. Asia-Pacific Angiotensin II Receptor Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Angiotensin II Receptor Sales Forecast by Country (2027-2032) & (k units) Table 118. Asia-Pacific Angiotensin II Receptor Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Angiotensin II Receptor Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Angiotensin II Receptor Market Share by Country (2021-2026) Table 122. Asia-Pacific Angiotensin II Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Angiotensin II Receptor Market Share Forecast by Country (2027-2032) Table 124. Latin America Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Latin America Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 126. Latin America Angiotensin II Receptor Sales Market Share by Country (2021-2026) Table 127. Latin America Angiotensin II Receptor Sales Forecast by Country (2027-2032) & (k units) Table 128. Latin America Angiotensin II Receptor Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Angiotensin II Receptor Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Angiotensin II Receptor Market Share by Country (2021-2026) Table 132. Latin America Angiotensin II Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Angiotensin II Receptor Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 136. Middle East and Africa Angiotensin II Receptor Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Angiotensin II Receptor Sales Forecast by Country (2027-2032) & (k units) Table 138. Middle East and Africa Angiotensin II Receptor Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Angiotensin II Receptor Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Angiotensin II Receptor Market Share by Country (2021-2026) Table 142. Middle East and Africa Angiotensin II Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Angiotensin II Receptor Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Angiotensin II Receptor Distributors List Table 147. Angiotensin II Receptor Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Angiotensin II Receptor Image Figure 2. Global Angiotensin II Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiotensin II Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Angiotensin II Receptor Sales (2021-2032) & (k units) Figure 5. MOR-107 Image Figure 6. Global MOR-107 Sales YoY Growth (2021-2032) & (k units) Figure 7. KDT-501 Image Figure 8. Global KDT-501 Sales YoY Growth (2021-2032) & (k units) Figure 9. EMA-401 Image Figure 10. Global EMA-401 Sales YoY Growth (2021-2032) & (k units) Figure 11. C-21 Image Figure 12. Global C-21 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Angiotensin II Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Angiotensin II Receptor Market Share by Type 2025 VS 2032 Figure 17. North America Angiotensin II Receptor Sales Market Share in Volume by Type in 2025 Figure 18. North America Angiotensin II Receptor Sales Market Share in Value by Type in 2025 Figure 19. Europe Angiotensin II Receptor Sales Market Share in Volume by Type in 2025 Figure 20. Europe Angiotensin II Receptor Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Angiotensin II Receptor Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Angiotensin II Receptor Sales Market Share in Value by Type in 2025 Figure 23. Latin America Angiotensin II Receptor Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Angiotensin II Receptor Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Angiotensin II Receptor Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Angiotensin II Receptor Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Angiotensin II Receptor Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Women's Health Image Figure 30. Global Women's Health Sales YoY Growth (2021-2032) & (k units) Figure 31. Immunology Image Figure 32. Global Immunology Sales YoY Growth (2021-2032) & (k units) Figure 33. Acute Ischemic Stroke Image Figure 34. Global Acute Ischemic Stroke Sales YoY Growth (2021-2032) & (k units) Figure 35. Respiratory Image Figure 36. Global Respiratory Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Angiotensin II Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Angiotensin II Receptor Market Share by Application 2025 VS 2032 Figure 41. North America Angiotensin II Receptor Sales Market Share in Volume by Application in 2025 Figure 42. North America Angiotensin II Receptor Sales Market Share in Value by Application in 2025 Figure 43. Europe Angiotensin II Receptor Sales Market Share in Volume by Application in 2025 Figure 44. Europe Angiotensin II Receptor Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Angiotensin II Receptor Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Angiotensin II Receptor Sales Market Share in Value by Application in 2025 Figure 47. Latin America Angiotensin II Receptor Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Angiotensin II Receptor Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Angiotensin II Receptor Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Angiotensin II Receptor Sales Market Share in Value by Application in 2025 Figure 51. North America Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Angiotensin II Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Angiotensin II Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Angiotensin II Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Angiotensin II Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Angiotensin II Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Angiotensin II Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Angiotensin II Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Angiotensin II Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Angiotensin II Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Angiotensin II Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Angiotensin II Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Angiotensin II Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Angiotensin II Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Angiotensin II Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Angiotensin II Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Angiotensin II Receptor Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Angiotensin II Receptor Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • MOR-107
  • KDT-501
  • EMA-401
  • C-21
  • Others
Applications
  • Women's Health
  • Immunology
  • Acute Ischemic Stroke
  • Respiratory
  • Others
Companies covered
  • CJ HealthCare Corp
  • MorphoSys AG
  • Vicore Pharma AB
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angiotensin II Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Angiotensin II Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Angiotensin II Receptor Market by Type
  6. 1.3.1 MOR-107
  7. 1.3.2 KDT-501
  8. 1.3.3 EMA-401
  9. 1.3.4 C-21
  10. 1.3.5 Others
  11. 1.4 Global Angiotensin II Receptor Market Size by Type
  12. 1.4.1 Global Angiotensin II Receptor Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Angiotensin II Receptor Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Angiotensin II Receptor Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Angiotensin II Receptor Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Angiotensin II Receptor Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Angiotensin II Receptor Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Angiotensin II Receptor Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Angiotensin II Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Angiotensin II Receptor Industry Trends
  2. 2.2 Angiotensin II Receptor Industry Drivers
  3. 2.3 Angiotensin II Receptor Industry Opportunities and Challenges
  4. 2.4 Angiotensin II Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Angiotensin II Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Angiotensin II Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Angiotensin II Receptor Price (2021-2026)
  4. 3.4 Global Angiotensin II Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Angiotensin II Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Angiotensin II Receptor Company, Product Type & Application
  7. 3.7 Global Angiotensin II Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Angiotensin II Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Angiotensin II Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Angiotensin II Receptor Tier 1, Tier 2, and Tier 3
4 Angiotensin II Receptor Regional Status and Outlook
  1. 4.1 Global Angiotensin II Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Angiotensin II Receptor Historic Market Size by Region
  3. 4.2.1 Global Angiotensin II Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Angiotensin II Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Angiotensin II Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Angiotensin II Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Angiotensin II Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Angiotensin II Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Angiotensin II Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Angiotensin II Receptor by Application
  1. 5.1 Angiotensin II Receptor Market by Application
  2. 5.1.1 Women's Health
  3. 5.1.2 Immunology
  4. 5.1.3 Acute Ischemic Stroke
  5. 5.1.4 Respiratory
  6. 5.1.5 Others
  7. 5.2 Global Angiotensin II Receptor Market Size by Application
  8. 5.2.1 Global Angiotensin II Receptor Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Angiotensin II Receptor Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Angiotensin II Receptor Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Angiotensin II Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Angiotensin II Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Angiotensin II Receptor Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Angiotensin II Receptor Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Angiotensin II Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CJ HealthCare Corp
  2. 6.1.1 CJ HealthCare Corp Company Information
  3. 6.1.2 CJ HealthCare Corp Business Overview
  4. 6.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CJ HealthCare Corp Angiotensin II Receptor Product Portfolio
  6. 6.1.5 CJ HealthCare Corp Recent Developments
  7. 6.2 MorphoSys AG
  8. 6.2.1 MorphoSys AG Company Information
  9. 6.2.2 MorphoSys AG Business Overview
  10. 6.2.3 MorphoSys AG Angiotensin II Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MorphoSys AG Angiotensin II Receptor Product Portfolio
  12. 6.2.5 MorphoSys AG Recent Developments
  13. 6.3 Vicore Pharma AB
  14. 6.3.1 Vicore Pharma AB Company Information
  15. 6.3.2 Vicore Pharma AB Business Overview
  16. 6.3.3 Vicore Pharma AB Angiotensin II Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vicore Pharma AB Angiotensin II Receptor Product Portfolio
  18. 6.3.5 Vicore Pharma AB Recent Developments
  19. 6.4 Novartis AG
  20. 6.4.1 Novartis AG Company Information
  21. 6.4.2 Novartis AG Business Overview
  22. 6.4.3 Novartis AG Angiotensin II Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AG Angiotensin II Receptor Product Portfolio
  24. 6.4.5 Novartis AG Recent Developments
7 North America by Country
  1. 7.1 North America Angiotensin II Receptor Sales by Country
  2. 7.1.1 North America Angiotensin II Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Angiotensin II Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Angiotensin II Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Angiotensin II Receptor Market Size by Country
  6. 7.2.1 North America Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Angiotensin II Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Angiotensin II Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Angiotensin II Receptor Sales by Country
  2. 8.1.1 Europe Angiotensin II Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Angiotensin II Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Angiotensin II Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Angiotensin II Receptor Market Size by Country
  6. 8.2.1 Europe Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Angiotensin II Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Angiotensin II Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Angiotensin II Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Angiotensin II Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Angiotensin II Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Angiotensin II Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Angiotensin II Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Angiotensin II Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Angiotensin II Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Angiotensin II Receptor Sales by Country
  2. 10.1.1 South America Angiotensin II Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Angiotensin II Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Angiotensin II Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Angiotensin II Receptor Market Size by Country
  6. 10.2.1 South America Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Angiotensin II Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Angiotensin II Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Angiotensin II Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Angiotensin II Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Angiotensin II Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Angiotensin II Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Angiotensin II Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Angiotensin II Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Angiotensin II Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Angiotensin II Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Angiotensin II Receptor Value Chain Analysis
  2. 12.1.1 Angiotensin II Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Angiotensin II Receptor Production Mode & Process
  7. 12.2 Angiotensin II Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Angiotensin II Receptor Distributors
  10. 12.2.3 Angiotensin II Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research